{
    "xml": "<topic id=\"PHP33262\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/pirfenidone\" basename=\"pirfenidone\" title=\"PIRFENIDONE\">\n<title>PIRFENIDONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1247\" namespace=\"/interactions/list-of-drug-interactions/pirfenidone\">Pirfenidone</xref>\n</p>\n<data name=\"vtmid\">438240001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_902761741\" title=\"Antifibrotics\">Antifibrotics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP73468\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/pirfenidone\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>The exact mechanism of action of pirfenidone is not yet understood, but it is believed to slow down the progression of idiopathic pulmonary fibrosis by exerting both antifibrotic and anti-inflammatory properties.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73148\" outputclass=\"indicationsAndDose\" rev=\"1.21\" parent=\"/drugs/pirfenidone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate idiopathic pulmonary fibrosis (initiated under specialist supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 267&#8239;mg 3 times a day for 7 days, then increased to 534&#8239;mg 3 times a day for 7 days, then increased to 801&#8239;mg 3 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Caution with concomitant use with ciprofloxacin&#8212;reduce dose of pirfenidone to 534&#8239;mg three times daily with high-dose ciprofloxacin (750&#8239;mg twice daily).</p>\n<p>Caution with concomitant use of drugs known to cause photosensitivity&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73601\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/pirfenidone\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Cigarette smoking</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62649\" outputclass=\"cautions\" rev=\"1.17\" parent=\"/drugs/pirfenidone\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Photosensitivity</p>\n<p>Avoid exposure to direct sunlight&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Treatment interruption</p>\n<p>If treatment is interrupted for 14 consecutive days or more, the initial 2 week titration regimen should be repeated; if treatment is interrupted for less than 14 consecutive days, the dose can be resumed at the previous daily dose without titration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73041\" outputclass=\"interactions\" rev=\"1.17\" parent=\"/drugs/pirfenidone\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (pirfenidone).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72681\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/pirfenidone\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal discomfort</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dry skin</ph>; <ph outputclass=\"sideEffect\">dysgeusia</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">gastritis</ph>; <ph outputclass=\"sideEffect\">gastro-oesophageal reflux disease</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hot flush</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">non-cardiac chest pain</ph>; <ph outputclass=\"sideEffect\">photosensitivity reaction</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">raised hepatic enzymes</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">somnolence</ph>; <ph outputclass=\"sideEffect\">upper respiratory tract infection</ph>; <ph outputclass=\"sideEffect\">urinary tract infection</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">weight loss</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Raised bilirubin in combination with raised hepatic transaminases</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>Gastrointestinal side-effects may require dose reduction or treatment interruption&#8212;consult product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72973\" outputclass=\"pregnancy\" parent=\"/drugs/pirfenidone\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62708\" outputclass=\"breastFeeding\" parent=\"/drugs/pirfenidone\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73246\" outputclass=\"hepaticImpairment\" parent=\"/drugs/pirfenidone\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in mild to moderate hepatic impairment, particularly if concomitant use of CYP1A2 inhibitors.</p>\n<p>Avoid use in severe hepatic impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72831\" outputclass=\"renalImpairment\" parent=\"/drugs/pirfenidone\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid use if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72274\" outputclass=\"monitoringRequirements\" parent=\"/drugs/pirfenidone\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor for weight loss.</p>\n<p>Test liver function before treatment, then at monthly intervals for the next 6 months, and then every 3 months thereafter; review if abnormal liver function tests&#8212;dose reduction, treatment interruption or discontinuation may be required (consult product literature).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72867\" outputclass=\"patientAndCarerAdvice\" rev=\"1.6\" parent=\"/drugs/pirfenidone\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundDrivingAndOtherTasks\">\n<title>Driving and skilled tasks</title>\n<sectiondiv>\n<p>Dizziness or malaise may affect performance of skilled tasks (e.g. driving).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71725\" outputclass=\"nationalFunding\" rev=\"1.18\" parent=\"/drugs/pirfenidone\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE </p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Pirfenidone for treating idiopathic pulmonary fibrosis (April 2013)</p>\r\n<p>Pirfenidone is recommended as an option for treating idiopathic pulmonary fibrosis only if:</p>\r\n<ul>\r\n<li>the patient has a forced vital capacity (FVC) between 50% and 80% predicted, <b>and</b>\r\n</li>\r\n<li>the manufacturer provides pirfenidone with the discount agreed in the patient access scheme.<p>Treatment should be discontinued if there is evidence of disease progression, defined as a decline in predicted FVC of 10% or more within any 12 month period.</p>\r\n<p>Patients currently receiving pirfenidone that is not recommended according to the above criteria should have the option to continue treatment until they and their clinician consider it appropriate to stop.</p>\r\n</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA282\">www.nice.org.uk/TA282</xref>\n</sectiondiv>\n</sectiondiv>\r\n<sectiondiv outputclass=\"smcDecisions\">\r\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\r\n<sectiondiv outputclass=\"smcDecision\">\r\n<sectiondiv>\r\n<p>The <i>Scottish Medicines Consortium</i> has advised (August 2013) that pirfenidone is accepted for restricted use within NHS Scotland for the treatment of mild to moderate idiopathic pulmonary fibrosis. Pirfenidone is restricted for use in patients with a predicted forced vital capacity less than or equal to 80%, and only whilst pirfenidone is available at the price agreed in the patient access scheme.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP33262-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/pirfenidone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75431\" title=\"Capsule\" namespace=\"/drugs/pirfenidone/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e132606\" href=\"#bnf_d1e132606\" namespace=\"/interactions/list-of-drug-interactions/pirfenidone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e132606</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e21662\" href=\"#bnf_d1e21662\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/quinolones/ciprofloxacin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e21662</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_195\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/quinolones/ciprofloxacin\" title=\"Ciprofloxacin\" count=\"1\" rel=\"backlink\">Ciprofloxacin</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1247\" namespace=\"/interactions/list-of-drug-interactions/pirfenidone\" title=\"Pirfenidone\" count=\"1\" rel=\"link\">Pirfenidone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75431\" namespace=\"/drugs/pirfenidone/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP33262",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/pirfenidone",
    "basename": "pirfenidone",
    "title": "PIRFENIDONE",
    "interactants": [
        {
            "id": "bnf_int_1247",
            "label": "Pirfenidone"
        }
    ],
    "vtmid": "438240001",
    "drugClassification": [
        "Antifibrotics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "The exact mechanism of action of pirfenidone is not yet understood, but it is believed to slow down the progression of idiopathic pulmonary fibrosis by exerting both antifibrotic and anti-inflammatory properties.",
                "html": "<p>The exact mechanism of action of pirfenidone is not yet understood, but it is believed to slow down the progression of idiopathic pulmonary fibrosis by exerting both antifibrotic and anti-inflammatory properties.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of mild to moderate idiopathic pulmonary fibrosis (initiated under specialist supervision)",
                        "html": "Treatment of mild to moderate idiopathic pulmonary fibrosis (initiated under specialist supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 267 mg 3 times a day for 7 days, then increased to 534 mg 3 times a day for 7 days, then increased to 801 mg 3 times a day.",
                        "html": "<p>Initially 267&#8239;mg 3 times a day for 7 days, then increased to 534&#8239;mg 3 times a day for 7 days, then increased to 801&#8239;mg 3 times a day.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Caution with concomitant use with ciprofloxacin&#8212;reduce dose of pirfenidone to 534 mg three times daily with high-dose ciprofloxacin (750 mg twice daily). Caution with concomitant use of drugs known to cause photosensitivity&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).",
                "html": "<p>Caution with concomitant use with ciprofloxacin&#8212;reduce dose of pirfenidone to 534&#8239;mg three times daily with high-dose ciprofloxacin (750&#8239;mg twice daily).</p> <p>Caution with concomitant use of drugs known to cause photosensitivity&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Cigarette smoking",
                "html": "Cigarette smoking"
            }
        ]
    },
    "cautions": {
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Photosensitivity",
                "textContent": "Avoid exposure to direct sunlight&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).",
                "html": "<p>Avoid exposure to direct sunlight&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).</p>"
            },
            {
                "type": "importantAdvice",
                "title": "Treatment interruption",
                "textContent": "If treatment is interrupted for 14 consecutive days or more, the initial 2 week titration regimen should be repeated; if treatment is interrupted for less than 14 consecutive days, the dose can be resumed at the previous daily dose without titration.",
                "html": "<p>If treatment is interrupted for 14 consecutive days or more, the initial 2 week titration regimen should be repeated; if treatment is interrupted for less than 14 consecutive days, the dose can be resumed at the previous daily dose without titration.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (pirfenidone).",
                "html": "<p>Appendix 1 (pirfenidone).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal discomfort",
                        "html": "Abdominal discomfort",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry skin",
                        "html": "dry skin",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dysgeusia",
                        "html": "dysgeusia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "erythema",
                        "html": "erythema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastritis",
                        "html": "gastritis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastro-oesophageal reflux disease",
                        "html": "gastro-oesophageal reflux disease",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hot flush",
                        "html": "hot flush",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "non-cardiac chest pain",
                        "html": "non-cardiac chest pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "photosensitivity reaction",
                        "html": "photosensitivity reaction",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "raised hepatic enzymes",
                        "html": "raised hepatic enzymes",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "somnolence",
                        "html": "somnolence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "upper respiratory tract infection",
                        "html": "upper respiratory tract infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "urinary tract infection",
                        "html": "urinary tract infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "weight loss",
                        "html": "weight loss",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Raised bilirubin in combination with raised hepatic transaminases",
                        "html": "Raised bilirubin in combination with raised hepatic transaminases",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "Gastrointestinal side-effects may require dose reduction or treatment interruption&#8212;consult product literature.",
                "html": "<p>Gastrointestinal side-effects may require dose reduction or treatment interruption&#8212;consult product literature.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in mild to moderate hepatic impairment, particularly if concomitant use of CYP1A2 inhibitors.\n\nAvoid use in severe hepatic impairment.",
                "html": "<p>Use with caution in mild to moderate hepatic impairment, particularly if concomitant use of CYP1A2 inhibitors.</p><p>Avoid use in severe hepatic impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid use if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Avoid use if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor for weight loss.\n\nTest liver function before treatment, then at monthly intervals for the next 6 months, and then every 3 months thereafter; review if abnormal liver function tests&#8212;dose reduction, treatment interruption or discontinuation may be required (consult product literature).",
                "html": "<p>Monitor for weight loss.</p><p>Test liver function before treatment, then at monthly intervals for the next 6 months, and then every 3 months thereafter; review if abnormal liver function tests&#8212;dose reduction, treatment interruption or discontinuation may be required (consult product literature).</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundDrivingAndOtherTasks": [
            {
                "type": "adviceAroundDrivingAndOtherTasks",
                "textContent": "Dizziness or malaise may affect performance of skilled tasks (e.g. driving).",
                "html": "<p>Dizziness or malaise may affect performance of skilled tasks (e.g. driving).</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA282",
                        "label": "www.nice.org.uk/TA282"
                    }
                ],
                "fundingIdentifier": "NICE",
                "textContent": "Pirfenidone for treating idiopathic pulmonary fibrosis (April 2013) Pirfenidone is recommended as an option for treating idiopathic pulmonary fibrosis only if: the patient has a forced vital capacity (FVC) between 50% and 80% predicted, and the manufacturer provides pirfenidone with the discount agreed in the patient access scheme.Treatment should be discontinued if there is evidence of disease progression, defined as a decline in predicted FVC of 10% or more within any 12 month period. Patients currently receiving pirfenidone that is not recommended according to the above criteria should have the option to continue treatment until they and their clinician consider it appropriate to stop.\n\nwww.nice.org.uk/TA282",
                "html": "<p outputclass=\"title\">Pirfenidone for treating idiopathic pulmonary fibrosis (April 2013)</p> <p>Pirfenidone is recommended as an option for treating idiopathic pulmonary fibrosis only if:</p> <ul> <li>the patient has a forced vital capacity (FVC) between 50% and 80% predicted, <b>and</b> </li> <li>the manufacturer provides pirfenidone with the discount agreed in the patient access scheme.<p>Treatment should be discontinued if there is evidence of disease progression, defined as a decline in predicted FVC of 10% or more within any 12 month period.</p> <p>Patients currently receiving pirfenidone that is not recommended according to the above criteria should have the option to continue treatment until they and their clinician consider it appropriate to stop.</p> </li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA282\">www.nice.org.uk/TA282</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75431",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e132606": [
            {
                "id": "bnf_d1e132606",
                "label": "bnf_d1e132606",
                "type": "#bnf_d1e132606"
            }
        ],
        "#bnf_d1e21662": [
            {
                "id": "bnf_d1e21662",
                "label": "bnf_d1e21662",
                "type": "#bnf_d1e21662"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_195",
                "label": "Ciprofloxacin",
                "type": "interaction"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1247",
                "label": "Pirfenidone",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75431",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}